Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Refractory Cirrhotic Ascites and Diabetes: Scoping Review Protocol

By systematically identifying and summarizing original studies that assess the efficacy of SGLT2i in this unique patient population, the review will provide insight into the therapeutic potential of this drug class beyond glycemic control. It will also highlight the strengths and limitations of the existing literature, identify key knowledge gaps, and suggest directions for future research. Ultimately, this review may support the rationale for further clinical investigation and the development of targeted therapies for a high-risk group of patients with limited treatment options.